Novo Nordisk's weight loss drug, potentially more potent than Wegovy, outshines Tesla with positive trial results. GLP-1 drugs, including Ozempic, spark national conversation on obesity. Speculation arises on how GLP-1RA drugs will impact food preference and eating behavior, affecting Big Industry. Concerns raised over Ozempic being likened to the next opioid crisis, with accusations of promoting obesity to profit from drug sales. Weight-loss drugs show promise in treating various diseases beyond obesity, with a surge of such drugs in clinical trials globally. High demand for weight-loss solutions in China due to rising obesity rates. Sanders seeks to challenge Novo Nordisk's pricing strategies for Ozempic, calling for grassroots involvement to combat exorbitant costs set by pharmaceutical companies.
Sanders is currently trying to meet with Novo Nordisk’s CEO and turn up the heat on Ozempic, but the grassroots needs to get involved again too. The idea that these companies can just demand whatever dollar amount they want is absurd, and it’s time we stopped putting up with it. https://t.co/SoOmvfm9xf
"Demand for weight-loss solutions is high in #China, where obesity rates among Chinese adults have more than doubled the past 2 decades...The % of adults classified as overweight & obese in 🇨🇳 reached 50.7% in 2022" https://t.co/D5DDR5yLbx
A tsunami of obesity drugs are in clinical trials 💉💊 Cc: @rtnarch @Noahpinion @PeterDiamandis @DKThomp https://t.co/qm5KCEVQ1U
Ozempic was invented by a Danish pharma company https://t.co/Yjq5UXUg9A
Could weight-loss drugs eat the world? Scientists are finding that anti-obesity medicines can also help treat many other diseases https://t.co/YFIEzhcPAB
PSA- Ozempic is the next opioid crisis. First we make everyone obese and pre-diabetic. Then we promote a miracle drug to fix it. Then Medicare funnels billions to Big Pharma, who use the $ to bribe doctors and regulatory agencies. Rinse, repeat. Huge target market. Beware. https://t.co/3vKwoS4PNa
Show of hands: How many of you would be surprised if the key lobbyists pushing Biden & Warren to make an embarrassing national issue out of fatty snack “shrinkflation” were the makers of Ozempic & Wegovy?
Le Roux's group speculates about the next phase of GLP-1RA research: how the drugs will impact food preference and eating behavior, which has major implications for Big Industry. https://t.co/NGDroVehJD
Opinion: Oprah kicked off a national conversation on obesity and GLP-1 drugs. Let’s have it. https://t.co/m4AvXDudkF
Novo Nordisk eclipses Tesla on positive trial results for a weight loss drug that may be more powerful than its own Wegovy. https://t.co/ifGxfM9DsF